{
  "company": {
    "name": "eversyn",
    "website": "https://eversyn.de/",
    "record": "https://startuphistory.org/c/eversyn.de"
  },
  "status": null,
  "history_since": "2023-02-03T20:24:37.000Z",
  "baseline": {
    "snapshot_id": "f3e8f000169be15460f41f03d8cbe62300a0f0ca8c0ca1ee5ca7b5db3bf128c0",
    "observed_at": "2023-02-03T20:24:37.000Z",
    "headline": "eversyn | for broader use of nucleotide sugars. than ever.",
    "description": "eversyn has designed and engineered pathways to produce nucleotide sugars by magnitude of orders cheaper than the current production costs. Building on that, we are engineering biocatalysts to produce",
    "evidence": "https://web.archive.org/web/20230203202437/https://www.eversyn.de/",
    "evidence_kind": "internet_archive",
    "facts": null,
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 1,
  "last_checked": "2026-11-05T14:06:03.195Z",
  "live_status": null,
  "messaging": [
    {
      "quote_observed_at": "2023-02-03T20:24:37.000Z",
      "variants": [
        {
          "headline": "eversyn | for broader use of nucleotide sugars. than ever.",
          "subhead": "eversyn has designed and engineered pathways to produce nucleotide sugars by magnitude of orders cheaper than the current production costs. Building on that, we are engineering biocatalysts to produce",
          "observed_at": "2023-02-03T20:24:37.000Z",
          "evidence": "https://web.archive.org/web/20230203202437/https://www.eversyn.de/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "eversyn | for broader use of nucleotide sugars. than ever.",
      "subhead": "eversyn has designed and engineered pathways to produce nucleotide sugars by magnitude of orders cheaper than the current production costs. Building on that, we are engineering biocatalysts to produce",
      "from": "2023-02-03T20:24:37.000Z",
      "to": "2023-02-03T20:24:37.000Z",
      "captures": 1,
      "evidence": "https://web.archive.org/web/20230203202437/https://www.eversyn.de/",
      "evidence_kind": "internet_archive",
      "seen": {
        "on": "2023-02-03T20:24:37.000Z"
      },
      "current": false
    },
    {
      "quote_observed_at": "2024-08-12T13:58:28.000Z",
      "variants": [
        {
          "headline": "eversyn | bioactive sugars for nutrition & biopharma",
          "subhead": "eversyn has designed and engineered pathways to produce nucleotide sugars by magnitude of orders cheaper than the current production costs. Building on that, we are engineering biocatalysts to produce",
          "observed_at": "2023-09-26T12:49:24.000Z",
          "evidence": "https://web.archive.org/web/20230926124924/https://www.eversyn.de/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "eversyn | bioactive sugars for nutrition & biopharma",
          "subhead": "eversyn has designed and engineered pathways to produce nucleotide sugars by magnitude of orders cheaper than the current production costs. Building on that, we are engineering biocatalysts to produce",
          "observed_at": "2024-03-25T05:34:07.000Z",
          "evidence": "https://web.archive.org/web/20240325053407/https://www.eversyn.de/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "eversyn | bioactive sugars for nutrition & biopharma",
          "subhead": "eversyn has designed and engineered pathways to produce nucleotide sugars by magnitude of orders cheaper than the current production costs. Building on that, we are engineering biocatalysts to produce",
          "observed_at": "2024-08-12T13:58:28.000Z",
          "evidence": "https://web.archive.org/web/20240812135828/https://www.eversyn.de/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "eversyn | bioactive sugars for nutrition & biopharma",
      "subhead": "eversyn has designed and engineered pathways to produce nucleotide sugars by magnitude of orders cheaper than the current production costs. Building on that, we are engineering biocatalysts to produce",
      "from": "2023-09-26T12:49:24.000Z",
      "to": "2024-08-12T13:58:28.000Z",
      "captures": 3,
      "evidence": "https://web.archive.org/web/20240812135828/https://www.eversyn.de/",
      "evidence_kind": "internet_archive",
      "seen": {
        "between": {
          "from": "2023-09-26T12:49:24.000Z",
          "to": "2024-08-12T13:58:28.000Z"
        }
      },
      "current": false
    },
    {
      "quote_observed_at": "2026-11-05T14:06:03.195Z",
      "variants": [
        {
          "headline": "eversyn | Making high-value glycans mainstream",
          "subhead": "Essential building blocks for glycans, with untapped potential in specialty carbohydrates and therapeutic proteins. eversyn makes these high-energy compounds affordable, unlocking new possibilities in",
          "observed_at": "2025-03-25T08:55:23.000Z",
          "evidence": "https://web.archive.org/web/20250325085523/https://www.eversyn.de/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "eversyn | Making high-value glycans mainstream",
          "subhead": "Essential building blocks for glycans, with untapped potential in specialty carbohydrates and therapeutic proteins. eversyn makes these high-energy compounds affordable, unlocking new possibilities in",
          "observed_at": "2025-09-16T01:40:48.000Z",
          "evidence": "https://web.archive.org/web/20250916014048/https://www.eversyn.de/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "eversyn | Making high-value glycans mainstream",
          "subhead": "Essential building blocks for glycans, with untapped potential in specialty carbohydrates and therapeutic proteins. eversyn makes these high-energy compounds affordable, unlocking new possibilities in",
          "observed_at": "2026-01-17T16:42:25.000Z",
          "evidence": "https://web.archive.org/web/20260117164225/https://www.eversyn.de/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "eversyn | Making high-value glycans mainstream",
          "subhead": "Essential building blocks for glycans, with untapped potential in specialty carbohydrates and therapeutic proteins. eversyn makes these high-energy compounds affordable, unlocking new possibilities in",
          "observed_at": "2026-06-12T05:18:41.000Z",
          "evidence": "https://web.archive.org/web/20260612051841/https://www.eversyn.de/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "eversyn | Making high-value glycans mainstream",
          "subhead": "Essential building blocks for glycans, with untapped potential in specialty carbohydrates and therapeutic proteins. eversyn makes these high-energy compounds affordable, unlocking new possibilities in",
          "observed_at": "2026-11-05T14:06:03.195Z",
          "evidence": "https://www.eversyn.de/",
          "evidence_kind": "live_capture"
        }
      ],
      "headline": "eversyn | Making high-value glycans mainstream",
      "subhead": "Essential building blocks for glycans, with untapped potential in specialty carbohydrates and therapeutic proteins. eversyn makes these high-energy compounds affordable, unlocking new possibilities in",
      "from": "2025-03-25T08:55:23.000Z",
      "to": "2026-11-05T14:06:03.195Z",
      "captures": 5,
      "evidence": "https://www.eversyn.de/",
      "evidence_kind": "live_capture",
      "seen": {
        "between": {
          "from": "2025-03-25T08:55:23.000Z",
          "to": "2026-11-05T14:06:03.195Z"
        }
      },
      "current": true
    }
  ],
  "changes": [
    {
      "n": 1,
      "id": "page-f3e8f000169be15460f41f03d8cbe62300a0f0ca8c0ca1ee5ca7b5db3bf128c0:075917d604f9087900057b1ce68ef6e4718783dc88dab3e94c585ae374e2de78:headline:503a74d258192b08",
      "before_evidence": "https://web.archive.org/web/20230203202437/https://www.eversyn.de/",
      "before_evidence_kind": "internet_archive",
      "kind": "headline",
      "label": "Headline",
      "summary": "Changed its homepage headline from “eversyn | for broader use of nucleotide sugars. than ever.” to “eversyn | bioactive sugars for nutrition & biopharma”.",
      "between": {
        "from": "2023-02-03T20:24:37.000Z",
        "to": "2023-09-26T12:49:24.000Z"
      },
      "evidence": "https://web.archive.org/web/20230926124924/https://www.eversyn.de/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": null
    },
    {
      "n": 2,
      "id": "page-8505de95d2a0e184c0e52f341781ca02214231361257efbd308654d693dd7711:272535e989085887c33179dc20cbe45fae1deaef8cd69895ffc1402a919f9979:headline:3fd7f30b8ceec55c",
      "before_evidence": "https://web.archive.org/web/20240812135828/https://www.eversyn.de/",
      "before_evidence_kind": "internet_archive",
      "kind": "headline",
      "label": "Headline",
      "summary": "Changed its homepage headline from “eversyn | bioactive sugars for nutrition & biopharma” to “eversyn | Making high-value glycans mainstream”.",
      "between": {
        "from": "2024-08-12T13:58:28.000Z",
        "to": "2025-03-25T08:55:23.000Z"
      },
      "evidence": "https://web.archive.org/web/20250325085523/https://www.eversyn.de/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": null
    },
    {
      "n": 3,
      "id": "page-e8d970349666286503cc6ffb3f4d13d180a938d9a1706bf7843f26bf586ba7cb:d9494d1c21796d4f9a1b3f7c04e517c1926dc61351f2d4d637f88b996b960b7e:logos:62d52d90e2d67d0e",
      "before_evidence": "https://web.archive.org/web/20250916014048/https://www.eversyn.de/",
      "before_evidence_kind": "internet_archive",
      "kind": "logos",
      "label": "New logos",
      "summary": "Added logos to its homepage: 024-179_edited.jpg and download (1)_edited.jpg.",
      "between": {
        "from": "2025-09-16T01:40:48.000Z",
        "to": "2026-01-17T16:42:25.000Z"
      },
      "evidence": "https://web.archive.org/web/20260117164225/https://www.eversyn.de/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": null
    }
  ],
  "update": null,
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “eversyn” company record, https://startuphistory.org/c/eversyn.de"
}